Chat with us
Research Assistance
Online
  • Please enter your first name.

India Synthetic Biology Market Size & Outlook, 2026-2033

The synthetic biology market in India is expected to reach a projected revenue of US$ 2,834.6 million by 2033. A compound annual growth rate of 21.5% is expected of India synthetic biology market from 2026 to 2033.

  • Biotechnology
    • Recombinant DNA & DNA Analysis
      • Synthetic Biology Market Outlook
Revenue, 2025 (US$M)
$603.6
Estimate, 2026 (US$M)
$723.1
Forecast, 2033 (US$M)
$2,834.6
CAGR, 2026 - 2033
21.5%
India Synthetic Biology Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the synthetic biology market

Every figure cited from GVR research

India synthetic biology market highlights

  • The India synthetic biology market generated a revenue of USD 603.6 million in 2025 and is expected to reach USD 2,834.6 million by 2033.
  • The India market is expected to grow at a CAGR of 21.5% from 2026 to 2033.
  • In terms of segment, pcr technology was the largest revenue generating technology in 2025.
  • PCR Technology is the most lucrative technology segment registering the fastest growth during the forecast period.


Synthetic biology market data book summary

Market revenue in 2025USD 603.6 million
Market revenue in 2033USD 2,834.6 million
Growth rate21.5% (CAGR from 2026 to 2033)
Largest segmentPcr technology
Fastest growing segmentPCR Technology
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationPCR Technology, Genome Editing Technology, NGS Technology, Bioprocessing Technology, Other Technologies
Key market players worldwideBasf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc


Other key industry trends

  • In terms of revenue, India accounted for 3.2% of the global synthetic biology market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China synthetic biology market is projected to lead the regional market in terms of revenue in 2033.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 7,760.6 million by 2033.

Indian companies are promoting synthetic biology and have adopted different approaches in funding, promotion, and regulation. They are developing a wide range of applications, from biofuels to industrial enzymes.

Some of the major companies are hybrid seed producers, with rapid adoption of GM crops in the country, making it the largest producer of Bt cotton. Moreover, large private companies such as Reliance Industries Limited are adding synthetic biology to their technology portfolios.

This factor indicates that large companies in the country recognize synthetic biology applications as a technology worth pursuing. Furthermore, the Indian government is aware of the importance of synthetic biology. It began two national initiatives—the National Biopharma Mission and the National Biofuel Policy. These initiatives are promoting R&D in biopharma & biofuels.

No credit card required*

Publish Date: Feb 21, 2025

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Synthetic Biology Market Companies

NameProfile# EmployeesHQWebsite
Merck KGaAView profile 62,345Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293www.emdgroup.com
Basf SEView profile 111,855Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056www.basf.com
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Illumina IncView profile 9,3005200 Illumina Way, San Diego, CA, United States, 92122www.illumina.com
Eurofins Scientific SEView profile 61,79823 Val Fleuri, Luxembourg, Luxembourg, L-1526www.eurofins.com
New England BiolabsView profile 501-1000Ipswich, Massachusetts, United States, North Americaneb.com
DNAstarView profile 51-100Madison, Wisconsin, United States, North Americawww.dnastar.com
Codexis IncView profile 174200 Penobscot Drive, Redwood, CA, United States, 94063www.codexis.com
SynthegoView profile 251-500Redwood City, California, United States, North Americawww.synthego.com
NovozymesView profile 5001-10000Bagsværd, Hovedstaden, Denmark, Europewww.novozymes.com/en#

India Synthetic Biology Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Synthetic Biology Market Outlook will help companies and investors design strategic landscapes.


Pcr Technology was the largest segment with a revenue share of 37.59% in 2025.

Horizon Databook has segmented the India synthetic biology market based on pcr technology, genome editing technology, ngs technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2021 to 2033.




Indian companies are promoting synthetic biology and have adopted different approaches in funding, promotion, and regulation. They are developing a wide range of applications, from biofuels to industrial enzymes.

Some of the major companies are hybrid seed producers, with rapid adoption of GM crops in the country, making it the largest producer of Bt cotton. Moreover, large private companies such as Reliance Industries Limited are adding synthetic biology to their technology portfolios.

This factor indicates that large companies in the country recognize synthetic biology applications as a technology worth pursuing. Furthermore, the Indian government is aware of the importance of synthetic biology. It began two national initiatives—the National Biopharma Mission and the National Biofuel Policy. These initiatives are promoting R&D in biopharma & biofuels.

  • India Synthetic Biology Market Technology Outlook (Revenue, USD Million , 2021-2033)
    • PCR Technology
    • Genome Editing Technology
    • NGS Technology
    • Bioprocessing Technology
    • Other Technologies
  • India Synthetic Biology Market Product Outlook (Revenue, USD Million , 2021-2033)
    • Enzymes
    • Oligonucleotide/Oligo Pools and Synthetic DNA
    • Cloning Technologies Kits
    • Xeno-Nucleic Acids
    • Chassis Organism
  • India Synthetic Biology Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Healthcare
    • Non-healthcare
  • India Synthetic Biology Market End Use Outlook (Revenue, USD Million , 2021-2033)
    • Biotechnology and Pharmaceutical companies
    • Academic and Government Research Institutes
    • Others

Reasons to subscribe to Synthetic Biology Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Synthetic Biology Market Outlook databook

  • Our clientele includes a mix of Synthetic Biology Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India Synthetic Biology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Synthetic Biology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

India Synthetic Biology Market, 2021-2033 (US$M)

No Access Stack Chart

India synthetic biology market statistics, by technology, 2021-2033 (US$M)

No Access Pie Chart

India synthetic biology market statistics, by technology, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more